Kohjin Bio Co., Ltd.JP:177A

Market cap
¥9.3B
P/E ratio
24.3x
Mar 31,
2022
Mar 31,
2023
Mar 31,
2024
Profit (loss) before income taxes9221,244636
Depreciation179168300
Increase (decrease) in allowance for doubtful accounts5120
Increase (decrease) in provision for bonuses-16-13
Increase (decrease) in retirement benefit liability-581
Interest and dividend income-0-1-1
Interest expenses393223
Share of loss (profit) of entities accounted for using equity method30-10-72
Loss on retirement of non-current assets-0-
Decrease (increase) in trade receivables-238301-94
Decrease (increase) in inventories9-581425
Decrease (increase) in accounts receivable - other-58-0
Decrease (increase) in consumption taxes refund receivable--4138
Increase (decrease) in trade payables73-1634
Increase (decrease) in accounts payable - other, and accrued expenses43-147
Increase (decrease) in accrued consumption taxes61-7445
Other, net-314-37
Subtotal1,1059231,321
Interest and dividends received011
Interest paid-41-32-23
Income taxes paid-302-430-475
Net cash provided by (used in) operating activities763461824
Purchase of property, plant and equipment-203-561-563
Payments for retirement of property, plant and equipment--0-
Purchase of intangible assets-1--0
Purchase of securities--10-
Loan advances--7-
Proceeds from collection of loans receivable-7-
Payments of leasehold and guarantee deposits--5-16
Proceeds from refund of leasehold and guarantee deposits14-2
Net cash provided by (used in) investing activities83-575-577
Proceeds from short-term borrowings300600600
Repayments of short-term borrowings--300-300
Proceeds from long-term borrowings--750
Repayments of long-term borrowings-662-410-940
Repayments of lease liabilities-23-21-32
Dividends paid-34-42-79
Net cash provided by (used in) financing activities-360-172-1
Effect of exchange rate change on cash and cash equivalents291519
Net increase (decrease) in cash and cash equivalents515-272264